230 related articles for article (PubMed ID: 30824181)
1. Increased soluble fms-like tyrosine kinase 1 after ischemia reperfusion contributes to adverse clinical outcomes following kidney transplantation.
Wewers TM; Mayer AB; Pfleiderer A; Beul K; Schmidt R; Heitplatz B; Van Marck V; Nolte I; Pavenstädt H; Reuter S; Brand M; Di Marco GS
Kidney Int; 2019 May; 95(5):1091-1102. PubMed ID: 30824181
[TBL] [Abstract][Full Text] [Related]
2. Increased soluble Flt-1 correlates with delayed graft function and early loss of peritubular capillaries in the kidney graft.
Chapal M; Néel M; Le Borgne F; Meffray E; Carceles O; Hourmant M; Giral M; Foucher Y; Moreau A; Fakhouri F
Transplantation; 2013 Oct; 96(8):739-44. PubMed ID: 23912175
[TBL] [Abstract][Full Text] [Related]
3. Anti-LG3 Antibodies Aggravate Renal Ischemia-Reperfusion Injury and Long-Term Renal Allograft Dysfunction.
Yang B; Dieudé M; Hamelin K; Hénault-Rondeau M; Patey N; Turgeon J; Lan S; Pomerleau L; Quesnel M; Peng J; Tremblay J; Shi Y; Chan JS; Hébert MJ; Cardinal H
Am J Transplant; 2016 Dec; 16(12):3416-3429. PubMed ID: 27172087
[TBL] [Abstract][Full Text] [Related]
4. The Study of Relationship between Serum Levels of Soluble fms-like Tyrosine Kinase-1 and Soluble Fibrinogen-like Protein 2 with Delayed Graft Function after Kidney Transplantation.
Akbari H; Hooshyar Z; Shabanitabar S; Salmani A; Nikoueinejad H; Einollahi B
Iran J Allergy Asthma Immunol; 2019 Aug; 18(4):412-418. PubMed ID: 31522449
[TBL] [Abstract][Full Text] [Related]
5. The determinants, biomarkers, and consequences of microvascular injury in kidney transplant recipients.
Doreille A; Dieudé M; Cardinal H
Am J Physiol Renal Physiol; 2019 Jan; 316(1):F9-F19. PubMed ID: 30379097
[TBL] [Abstract][Full Text] [Related]
6. Ischemia reperfusion injury in kidney transplantation: A case report.
Philipponnet C; Aniort J; Garrouste C; Kemeny JL; Heng AE
Medicine (Baltimore); 2018 Dec; 97(52):e13650. PubMed ID: 30593134
[TBL] [Abstract][Full Text] [Related]
7. Circulating Soluble Fms-like Tyrosine Kinase in Renal Diseases Other than Preeclampsia.
Wewers TM; Schulz A; Nolte I; Pavenstädt H; Brand M; Di Marco GS
J Am Soc Nephrol; 2021 Aug; 32(8):1853-1863. PubMed ID: 34155060
[TBL] [Abstract][Full Text] [Related]
8. Reduction of circulating soluble fms-like tyrosine kinase-1 plays a significant role in renal dysfunction-associated aggravation of atherosclerosis.
Onoue K; Uemura S; Takeda Y; Somekawa S; Iwama H; Imagawa K; Nishida T; Morikawa Y; Takemoto Y; Asai O; Soeda T; Okayama S; Ishigami K; Nakatani K; Kawata H; Horii M; Nakajima T; Akai Y; Iwano M; Saito Y
Circulation; 2009 Dec; 120(24):2470-7. PubMed ID: 19948974
[TBL] [Abstract][Full Text] [Related]
9. Urinary IL-8 is a marker of early and long-term graft function after renal transplantation.
Kwiatkowska E; Domański L; Bober J; Safranow K; Szymańska-Pasternak J; Sulecka A; Pawlik A; Ciechanowski K; Kwiatkowski S
Ren Fail; 2017 Nov; 39(1):484-490. PubMed ID: 28494217
[TBL] [Abstract][Full Text] [Related]
10. A novel therapy to attenuate acute kidney injury and ischemic allograft damage after allogenic kidney transplantation in mice.
Gueler F; Shushakova N; Mengel M; Hueper K; Chen R; Liu X; Park JK; Haller H; Wensvoort G; Rong S
PLoS One; 2015; 10(1):e0115709. PubMed ID: 25617900
[TBL] [Abstract][Full Text] [Related]
11. Acute Kidney Injury, Microvascular Rarefaction, and Estimated Glomerular Filtration Rate in Kidney Transplant Recipients.
Doreille A; Azzi F; Larivière-Beaudoin S; Karakeussian-Rimbaud A; Trudel D; Hébert MJ; Dieudé M; Patey N; Cardinal H
Clin J Am Soc Nephrol; 2021 Mar; 16(3):415-426. PubMed ID: 33648972
[TBL] [Abstract][Full Text] [Related]
12. Complement Modulation of Anti-Aging Factor Klotho in Ischemia/Reperfusion Injury and Delayed Graft Function.
Castellano G; Intini A; Stasi A; Divella C; Gigante M; Pontrelli P; Franzin R; Accetturo M; Zito A; Fiorentino M; Montinaro V; Lucarelli G; Ditonno P; Battaglia M; Crovace A; Staffieri F; Oortwijn B; van Amersfoort E; Pertosa G; Grandaliano G; Gesualdo L
Am J Transplant; 2016 Jan; 16(1):325-33. PubMed ID: 26280899
[TBL] [Abstract][Full Text] [Related]
13. Renal ischemia-reperfusion injury causes hypertension and renal perfusion impairment in the CD1 mice which promotes progressive renal fibrosis.
Greite R; Thorenz A; Chen R; Jang MS; Rong S; Brownstein MJ; Tewes S; Wang L; Baniassad B; Kirsch T; Bräsen JH; Lichtinghagen R; Meier M; Haller H; Hueper K; Gueler F
Am J Physiol Renal Physiol; 2018 May; 314(5):F881-F892. PubMed ID: 29357437
[TBL] [Abstract][Full Text] [Related]
14. Elevated Soluble Fms-Like Tyrosine Kinase-1 and Placental-Like Growth Factor Levels Are Associated With Development and Mortality Risk in Heart Failure.
Hammadah M; Georgiopoulou VV; Kalogeropoulos AP; Weber M; Wang X; Samara MA; Wu Y; Butler J; Tang WH
Circ Heart Fail; 2016 Jan; 9(1):e002115. PubMed ID: 26699385
[TBL] [Abstract][Full Text] [Related]
15. The protective function of miR-378 in the ischemia-reperfusion injury during renal transplantation and subsequent interstitial fibrosis of the renal allograft.
Xiong L; Ding S; Yang T
Int Urol Nephrol; 2020 Sep; 52(9):1791-1800. PubMed ID: 32661619
[TBL] [Abstract][Full Text] [Related]
16. Caspase-3 Is a Pivotal Regulator of Microvascular Rarefaction and Renal Fibrosis after Ischemia-Reperfusion Injury.
Yang B; Lan S; Dieudé M; Sabo-Vatasescu JP; Karakeussian-Rimbaud A; Turgeon J; Qi S; Gunaratnam L; Patey N; Hébert MJ
J Am Soc Nephrol; 2018 Jul; 29(7):1900-1916. PubMed ID: 29925521
[No Abstract] [Full Text] [Related]
17. Stem cell factor, interleukin-16, and interleukin-2 receptor alpha are predictive biomarkers for delayed and slow graft function.
Alachkar N; Ugarte R; Huang E; Womer KL; Montgomery R; Kraus E; Rabb H
Transplant Proc; 2010 Nov; 42(9):3399-405. PubMed ID: 21094786
[TBL] [Abstract][Full Text] [Related]
18. Reviewing the pathogenesis of antibody-mediated rejection and renal graft pathology after kidney transplantation.
Morozumi K; Takeda A; Otsuka Y; Horike K; Gotoh N; Narumi S; Watarai Y; Kobayashi T
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():4-8. PubMed ID: 26971899
[TBL] [Abstract][Full Text] [Related]
19. Soluble fms-Like Tyrosine Kinase 1 as a Link Between Angiogenesis and Endothelial Dysfunction in Pediatric Patients With β-Thalassemia Intermedia.
Tantawy AAG; Adly AAM; Ismail EAR; Youssef OI; Ali ME
Clin Appl Thromb Hemost; 2017 Nov; 23(8):943-950. PubMed ID: 28301910
[TBL] [Abstract][Full Text] [Related]
20. Capillary C4d and Kidney Allograft Outcome in Relation to Morphologic Lesions Suggestive of Antibody-Mediated Rejection.
Kikić Ž; Kainz A; Kozakowski N; Oberbauer R; Regele H; Bond G; Böhmig GA
Clin J Am Soc Nephrol; 2015 Aug; 10(8):1435-43. PubMed ID: 26071493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
